Gregory Oakes - Jun 20, 2022 Form 3 Insider Report for Landos Biopharma, Inc. (LABP)

Role: Chief Executive Officer, Director
Signature: /s/ Eric W. Blanchard, Attorney-in-Fact
Stock symbol: LABP
Transactions as of: Jun 20, 2022
Transactions value $: $0
Form type: 3
Date filed: 6/22/2022, 04:27 PM
Previous filing: Jan 3, 2022
Next filing: Mar 2, 2023

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No securities are beneficially owned.